SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001561743-20-000070
Filing Date
2020-09-16
Accepted
2020-09-16 08:12:48
Documents
15
Period of Report
2020-09-16
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K kin-20200916.htm   iXBRL 8-K 47018
2 EX-99.1 prparvovirusprophylaxi.htm EX-99.1 20578
  Complete submission text file 0001561743-20-000070.txt   259741

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kin-20200916.xsd EX-101.SCH 2565
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT kin-20200916_cal.xml EX-101.CAL 713
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT kin-20200916_def.xml EX-101.DEF 16701
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kin-20200916_lab.xml EX-101.LAB 30978
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kin-20200916_pre.xml EX-101.PRE 17384
8 EXTRACTED XBRL INSTANCE DOCUMENT kin-20200916_htm.xml XML 13785
Mailing Address 1555 BAYSHORE HIGHWAY, SUITE 200 BURLINGAME CA 94010
Business Address 1555 BAYSHORE HIGHWAY, SUITE 200 BURLINGAME CA 94010 650-701-7901
Kindred Biosciences, Inc. (Filer) CIK: 0001561743 (see all company filings)

IRS No.: 461160142 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36225 | Film No.: 201177437
SIC: 2834 Pharmaceutical Preparations